[Restenosis following coronary dilatation].
Restenoses following successful coronary angioplasty occur in about 30 to 35% and are the most important limitative factor of this method. The etiology of restenosis is multifactorial. A beneficial effect in reducing restenosis could not be demonstrated for any drug in the clinical stage. First results with the administration of n-3-fatty acids revealed a favourable influence on recurrence. Further on, the value of newer interventional methods on restenosis rate is also uncertain. Thus, the problem of restenosis remains unresolved.
Leisch
F
F
I. Medizinischen Abteilung, a.ö. Krankenhauses der Stadt Linz.
D015906:Angioplasty, Balloon, Coronary; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D012008:Recurrence
Restenosierung nach Koronardilatation.